Abstract:Background Latent autoimmune diabetes in adults (LADA) is a form of autoimmune diabetes with heterogeneous features. This study aimed to investigate the persistent status of glutamic acid decarboxylase antibody (GADA) in patients with LADA and its association with clinical characteristics.Methods This 3-year follow-up study enrolled 107 LADA and 40 type 2 diabetes mellitus (T2DM) patients from October 2005 to December 2013. GADA titer, epitopes, and clinical characteristics (including fasting C-peptide and HbA(1c)) in LADA patients were assayed annually. The human leukocyte antigen DQ (HLA-DQ) genotypes were also analysed. The relationship between the persistence of GADA and the clinical characteristics was investigated in LADA patients.Results After 3-year follow-up, 36.5% (39/107) LADA patients remained GADA positive (persistently positive group), 19.6% (21/107) patients fluctuated positively and negatively (fluctuating group), and 43.9% (47/107) patients became GADA negative, among which 61.7% (29/47) seroconversions occurred within 6 months of follow-up (transiently positive group). The GADA persistently positive group possessed higher titer of GADA than transiently positive group and fluctuant group (all p=0.000), higher reactivities to middle and C-terminal regions of GAD65 than those in transiently positive group (p=0.001 and p=0.000, respectively), and lower baseline fasting C-peptide level than T2DM patients and transiently positive group [415(31-1862) vs 620(220-1658) pmol/L, p=0.014; and 415(31-1862) vs 705(64-1541) pmol/L, p=0.017, respectively]. The GADA transiently positive group retained a higher HbA(1c) level when compared with T2DM patients (p=0.023). In addition, the three LADA groups shared similar frequencies of HLA-DQ susceptible haplotypes that were higher as compared with T2DM. The GADA persistently positive group had a higher annual declining rate in fasting C-peptide than T2DM patients [-14%(-174-33%) vs -1%(-27-28%), p=0.007].Conclusion The LADA patients with GADA transient positivity account for a large proportion, whose clinical characteristics and HLA-DQ haplotypes are different from those of T2DM. The patients with high titer GADA and reactivities to GADA65 middle and C-terminal regions showed a persistent GADA positivity, in which a worse baseline and accelerated decline of beta-cell function need early intervention in the practice. Copyright (C) 2016 John Wiley & Sons, Ltd.

Increased risk for endocrine autoimmunity in Italian type 2 diabetic patients with GAD65 autoantibodies

Epitope analysis of GAD65 autoantibodies in adult-onset type 1 diabetes and latent autoimmune diabetes in adults with thyroid autoimmunity

Analvsis of GAD65 autoantibody epitooes in type 1 diabetes and LADA patients with versus without thyroid autoimmunity

GAD65Abs Are Not Associated With Beta-Cell Dysfunction in Patients With T2D in the GRADE Study

The Study on the Risk of Other Endocrine Glands Autoimmune Diseases in Patients with Type 1 Diabetes Mellitus

GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial

[Abnormal T Cell Autoimmunity Against GAD65 in LADA Patients].

Anti‐GAD65 Autoantibody in Taiwanese Patients with Insulin‐dependent Diabetes Mellitus: Effect of HLA on Anti‐gad65 Positivity and Clinical Characteristics

High Titre of Antiglutamic Acid Decarboxylase Autoantibody is a Strong Predictor of the Development of Thyroid Autoimmunity in Patients with Type 1 Diabetes and Latent Autoimmune Diabetes in Adults

GAD-Ab positive type 1 diabetics are at risk for thyroid autoimmunity

Latent Autoimmune Diabetes in Adults with Low-Titer GAD Antibodies: Similar Disease Progression with Type 2 Diabetes

Type 1 diabetes, celiac disease, and autoimmune thyroiditis autoantibodies in population-based type 2 diabetes patients

GAD65 antibody epitope patterns of Type 1 diabetes and LADA patients

Glutamic Acid Decarboxylase Autoantibody Detection by Electrochemiluminescence Assay Identifies Latent Autoimmune Diabetes in Adults with Poor Islet Function.

GAD autoantibody affinity and epitope specificity identify distinct immunization profiles in children at risk for type 1 diabetes

GAD autoantibody affinity in schoolchildren from the general population

High glutamic acid decarboxylase antibody titers may be associated with a decline in β-cell function over time and future insulin deficiency in latent autoimmune diabetes in adults

Persistence of Glutamic Acid Decarboxylase Antibody (GADA) is Associated with Clinical Characteristics of Latent Autoimmune Diabetes in Adults: a Prospective Study with 3-Year Follow-Up.

[Relation Between Insulin Resistance and Glutamic Acid Decarboxylase Antibody Titers in Latent Autoimmune Diabetes in Adults].

The diabetic antigen glutamic acid decarboxylase (GAD 65) in the human peripheral blood

Glutamic Acid Decarboxylase 65 Autoantibody Levels Discriminate Two Subtypes Of Latent Autoimmune Diabetes In Adults